Application Nr Approved Date Route Status External Links
ANDA202032 2011-11-17 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lamivudine Tablets Are A Nucleoside Analogue Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus Type 1 (hiv-1) Infection. Limitations Of Use: The Dosage Of This Product Is For Hiv-1 And Not For Hbv. Lamivudine Tablets Are A Nucleoside Analogue Reverse Transcriptase Inhibitor Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. Limitations Of Use: The Dosage Of This Product Is For Hiv-1 And Not For Hbv. (1)

All Formulated Excipients (5 Total)

Name Structure Kind Function Status
1. Hypromelloses HYPROMELLOSES Unresolved
2. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
3. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
4. Polyethylene Glycols POLYETHYLENE GLYCOLS Unresolved
5. Polysorbate 80 POLYSORBATE 80 Unresolved AF-Antifoaming (or defoaming) agent , EMUL-Emulsifier , MISC-Miscellaneous , SDA-Solubilizing & dispersing agent REG-Food additives for which a petition has been filed and a regulation issued.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lamivudine LAMIVUDINE ZINC12346

Comments